RNA – avidity biosciences, inc. (US:NASDAQ)
Stock Stats
News
Avidity Biosciences Announces Expected Record Date for Spin-Off [Yahoo! Finance]
Avidity Biosciences Announces Expected Record Date for Spin-Off
Avidity Biosciences (NASDAQ:RNA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
JPM26: Novartis strengthens neuroscience portfolio with bolt-on deals [Yahoo! Finance]
SciNeuro and Novartis sign global licensing deal for Alzheimer's antibody [Yahoo! Finance]
Form SCHEDULE 13G/A Avidity Biosciences, Filed by: WELLINGTON MANAGEMENT GROUP LLP
Form 8-K Avidity Biosciences, For: Feb 02
Form DEFA14A Avidity Biosciences,
Form DEFM14A Avidity Biosciences,
Form 4 Avidity Biosciences, For: Jan 21 Filed by: Flanagan W. Michael
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.